Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

25

Number of overlapping holdings

29.8%

% of WDNA's 90 holdings also in GNOM

64.1%

% of GNOM's 39 holdings also in WDNA

Overlap by Weight
Sector Drift (WDNA minus GNOM)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in WDNA
Weight
in GNOM
Overlap
NATERA INC 3.7% 7.1% 3.7%
VERACYTE INC 2.1% 5.5% 2.1%
GILEAD SCIENCES INC 1.9% 3.4% 1.9%
VERTEX PHARMACEUTICALS INC 1.8% 3.0% 1.8%
ALNYLAM PHARMACEUTICALS INC 1.6% 4.5% 1.6%

Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to GNOM
TWIST BIOSCIENCE CORP. 3.3%
NOVOZYMES A/S-B SHARES 2.9%
ELI LILLY & CO 2.7%
BLUEPRINT MEDICINES CORP. 2.6%
VERICEL CORPORATION 2.6%
BRIDGEBIO PHARMA, INC. 2.4%
AGIOS PHARMACEUTICALS INC 1.9%
UNITED THERAPEUTICS CORP 1.7%
AMGEN INC 1.7%
NOVARTIS AG 1.7%
WDNA Underweight Relative to GNOM
AGILENT TECHNOLOGIES INC -4.4%
LEGEND BIOTECH CORPORATION SPONSORED -4.2%
BIOMARIN PHARMACEUTICAL INC -3.9%
BIONTECH SE SPONSORED ADR -3.8%
GENSCRIPT BIOTECH CORPORATION -3.8%
CRISPR THERAPEUTICS AG -3.4%
VERACYTE INC -3.4%
NATERA INC -3.4%
AVIDITY BIOSCIENCES INC -3.3%
BIO-TECHNE CORPORATION -2.9%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY